首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1082198篇
  免费   74059篇
  国内免费   1369篇
耳鼻咽喉   15104篇
儿科学   35010篇
妇产科学   28930篇
基础医学   154806篇
口腔科学   29860篇
临床医学   95810篇
内科学   205327篇
皮肤病学   24501篇
神经病学   82486篇
特种医学   43408篇
外国民族医学   201篇
外科学   164050篇
综合类   21806篇
现状与发展   1篇
一般理论   270篇
预防医学   75373篇
眼科学   24626篇
药学   86755篇
  7篇
中国医学   2817篇
肿瘤学   66478篇
  2019年   7920篇
  2018年   11479篇
  2017年   9072篇
  2016年   10274篇
  2015年   11444篇
  2014年   15496篇
  2013年   22586篇
  2012年   31074篇
  2011年   32900篇
  2010年   19247篇
  2009年   18106篇
  2008年   30438篇
  2007年   32520篇
  2006年   33178篇
  2005年   31471篇
  2004年   30156篇
  2003年   28930篇
  2002年   27883篇
  2001年   60348篇
  2000年   61788篇
  1999年   51239篇
  1998年   12580篇
  1997年   11114篇
  1996年   11112篇
  1995年   10430篇
  1994年   9455篇
  1993年   8952篇
  1992年   38002篇
  1991年   36502篇
  1990年   35919篇
  1989年   34481篇
  1988年   31036篇
  1987年   30131篇
  1986年   28345篇
  1985年   26563篇
  1984年   19294篇
  1983年   16209篇
  1982年   8878篇
  1979年   17100篇
  1978年   11461篇
  1977年   10288篇
  1976年   8889篇
  1975年   10125篇
  1974年   11733篇
  1973年   11321篇
  1972年   10797篇
  1971年   10155篇
  1970年   9306篇
  1969年   8989篇
  1968年   7942篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional...  相似文献   
3.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
4.
PurposeUnderstanding the value of genetic screening and testing for monogenic disorders requires high-quality, methodologically robust economic evaluations. This systematic review sought to assess the methodological quality among such studies and examined opportunities for improvement.MethodsWe searched PubMed, Cochrane, Embase, and Web of Science for economic evaluations of genetic screening/testing (2013-2019). Methodological rigor and adherence to best practices were systematically assessed using the British Medical Journal checklist.ResultsAcross the 47 identified studies, there were substantial variations in modeling approaches, reporting detail, and sophistication. Models ranged from simple decision trees to individual-level microsimulations that compared between 2 and >20 alternative interventions. Many studies failed to report sufficient detail to enable replication or did not justify modeling assumptions, especially for costing methods and utility values. Meta-analyses, systematic reviews, or calibration were rarely used to derive parameter estimates. Nearly all studies conducted some sensitivity analysis, and more sophisticated studies implemented probabilistic sensitivity/uncertainty analysis, threshold analysis, and value of information analysis.ConclusionWe describe a heterogeneous body of work and present recommendations and exemplar studies across the methodological domains of (1) perspective, scope, and parameter selection; (2) use of uncertainty/sensitivity analyses; and (3) reporting transparency for improvement in the economic evaluation of genetic screening/testing.  相似文献   
5.
6.
7.
8.
9.
Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor necrosis factor alpha therapy has impacted the clinical course of IBD in those patients who do not respond to conventional treatment, so there is a need to develop new therapies and markers of treatment response. Various pathways involved in the development of the disease are known and the new therapies have focused on blocking the inflammatory process at the gastrointestinal level by oral, intravenous, subcutaneous, and topical route. All these new therapies can lead to more personalized treatments with higher success rates and fewer relapses. These treatments have not only focused on clinical remission, but also on achieving macroscopic changes at the endoscopic level and microscopic changes by achieving mucosal healing. These treatments are mainly based on modifying signaling pathways, by blocking receptors or ligands, reducing cell migration and maintaining the integrity of the epithelial barrier. Therefore, this review presents the efficacy and safety of the new treatments that are currently under study and the advances that have been made in this area in recent years.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号